NASDAQ · Medical - Care Facilities

INNV (INNV) Stock

$11.36 -2.07% NASDAQ: INNV Healthcare

Valuation

MetricValue
Price$11.36
Market Cap$1.54B
P/E Ratio24.28
P/B Ratio5.47
P/S Ratio1.32
EPS (TTM)$0.38
52-Week High$12.52
52-Week Low$3.13
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-5.88%
ROA0.65%
ROCE-11.41%
Gross Margin20.75%
Operating Margin3.91%
Net Margin-2.35%
Debt/Equity0.41
Current Ratio1.07

Annual Financials (USD)

Metric20212022202320242025
Revenue$638.0M$699.0M$688.0M$764.0M$854.0M
Operating Profit$75.0M$-4.0M$-49.0M$-23.0M$-30.0M
Net Profit$-44.0M$-7.0M$-41.0M$-21.0M$-30.0M
EPS$-0.33$-0.05$-0.30$-0.16$-0.22
Op Margin11.7%-0.6%-7.2%-3.0%-3.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$539.0M$563.0M$548.0M$580.0M$557.0M
Total Liabilities$181.0M$209.0M$248.0M$280.0M$294.0M
Cash$204.0M$184.0M$57.0M$57.0M$64.0M
Borrowings$83.0M$85.0M$113.0M$113.0M$101.0M

Latest News

Why InnovAge Holding (INNV) Is Down 9.0% After Raising 2026 Revenue Guidance Amid Wider Loss Simply Wall St. · May 13, 2026 InnovAge Appoints Jennifer Browne as Chief Operating Officer MT Newswires · May 12, 2026 InnovAge Appoints Jennifer Browne as President and Chief Operating Officer GlobeNewswire · May 12, 2026 InnovAge (INNV) Q3 2026 Earnings Transcript Motley Fool · May 6, 2026 InnovAge Holding Corp. Q3 2026 Earnings Call Summary Moby · May 6, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-8.0M$27.0M$-37.0M$-37.0M$33.0M
Investing Cash Flow$-37.0M$-78.0M$-34.0M$-34.0M$-12.0M
Financing Cash Flow$265.0M$0$1.0M$1.0M$-9.0M
Net Cash Flow$89.0M$-19.0M$-70.0M$-70.0M$8.0M
Free Cash Flow$-25.0M$-11.0M$-45.0M$-45.0M$27.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA51.28
FCF Yield3.10%
Quick Ratio1.03
Interest Coverage-6.00
Return 1Y179.75%
Return 3Y55.42%
Return 5Y-36.42%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About INNV

INNV is led by CEO Patrick Blair, publicly traded since 2021.

INNV stock trades at $11.36 with a market capitalization of $1.54B. The stock is valued at a price-to-earnings (P/E) ratio of 24.28, price-to-book of 5.47, price-to-sales of 1.32. Over the past 52 weeks the stock has ranged between $3.13 and $12.52, and currently trades 9.3% below its 52-week high.

On profitability, INNV generates a return on equity (ROE) of -5.88%, return on capital employed of -11.41%, an operating margin of 3.91%, a net profit margin of -2.35%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides